

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 8.27898823 |
| 2 | central nervous system myelination (GO:0022010) | 8.27898823 |
| 3 | response to pheromone (GO:0019236) | 7.57851116 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 7.42538961 |
| 5 | thrombin receptor signaling pathway (GO:0070493) | 7.33880498 |
| 6 | protein neddylation (GO:0045116) | 7.15120056 |
| 7 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 6.78107650 |
| 8 | fatty acid elongation (GO:0030497) | 6.76059061 |
| 9 | import into cell (GO:0098657) | 6.41495103 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.06272337 |
| 11 | regulation of platelet aggregation (GO:0090330) | 5.96224469 |
| 12 | angiogenesis involved in wound healing (GO:0060055) | 5.74430551 |
| 13 | regulation of platelet activation (GO:0010543) | 5.65685496 |
| 14 | blood coagulation, intrinsic pathway (GO:0007597) | 5.38698798 |
| 15 | regulation of integrin-mediated signaling pathway (GO:2001044) | 5.34503154 |
| 16 | vitamin biosynthetic process (GO:0009110) | 5.32522283 |
| 17 | amyloid precursor protein metabolic process (GO:0042982) | 5.11085898 |
| 18 | myelination (GO:0042552) | 5.05985639 |
| 19 | ensheathment of neurons (GO:0007272) | 5.02648588 |
| 20 | axon ensheathment (GO:0008366) | 5.02648588 |
| 21 | adenosine receptor signaling pathway (GO:0001973) | 5.02217627 |
| 22 | platelet aggregation (GO:0070527) | 5.01400286 |
| 23 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.99130613 |
| 24 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.96328240 |
| 25 | low-density lipoprotein particle remodeling (GO:0034374) | 4.95543761 |
| 26 | response to methylmercury (GO:0051597) | 4.90632545 |
| 27 | L-amino acid import (GO:0043092) | 4.89358096 |
| 28 | positive regulation of actin cytoskeleton reorganization (GO:2000251) | 4.79783781 |
| 29 | lipoxygenase pathway (GO:0019372) | 4.75786082 |
| 30 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.73707219 |
| 31 | vitamin transmembrane transport (GO:0035461) | 4.68818639 |
| 32 | positive regulation of cAMP-mediated signaling (GO:0043950) | 4.67534372 |
| 33 | heart trabecula formation (GO:0060347) | 4.66318750 |
| 34 | negative regulation of platelet activation (GO:0010544) | 4.62537904 |
| 35 | neutrophil activation (GO:0042119) | 4.52037168 |
| 36 | negative regulation of norepinephrine secretion (GO:0010700) | 4.50231194 |
| 37 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 4.43192074 |
| 38 | negative regulation of heart rate (GO:0010459) | 4.41202466 |
| 39 | positive regulation of mast cell activation (GO:0033005) | 4.38393619 |
| 40 | positive regulation of lipid kinase activity (GO:0090218) | 4.35910451 |
| 41 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.35332780 |
| 42 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.21373618 |
| 43 | platelet formation (GO:0030220) | 4.20677982 |
| 44 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 4.08044827 |
| 45 | cholesterol biosynthetic process (GO:0006695) | 4.07848093 |
| 46 | positive regulation of macrophage differentiation (GO:0045651) | 4.06909412 |
| 47 | platelet degranulation (GO:0002576) | 4.06639078 |
| 48 | positive regulation of blood coagulation (GO:0030194) | 4.05740432 |
| 49 | positive regulation of hemostasis (GO:1900048) | 4.05740432 |
| 50 | nucleotide transmembrane transport (GO:1901679) | 4.04625616 |
| 51 | granulocyte activation (GO:0036230) | 3.94651124 |
| 52 | regulation of integrin activation (GO:0033623) | 3.94240959 |
| 53 | myelin maintenance (GO:0043217) | 3.91618770 |
| 54 | ear development (GO:0043583) | 3.91065235 |
| 55 | negative regulation of protein localization to cell surface (GO:2000009) | 3.90273745 |
| 56 | protein targeting to Golgi (GO:0000042) | 3.90222991 |
| 57 | positive regulation of dendritic spine development (GO:0060999) | 3.88879662 |
| 58 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.88416899 |
| 59 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.83943948 |
| 60 | positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552) | 3.81830220 |
| 61 | sprouting angiogenesis (GO:0002040) | 3.81188180 |
| 62 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.79950705 |
| 63 | synaptic vesicle maturation (GO:0016188) | 3.79199705 |
| 64 | sterol biosynthetic process (GO:0016126) | 3.78374552 |
| 65 | regulation of collateral sprouting (GO:0048670) | 3.70837548 |
| 66 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.70053903 |
| 67 | positive regulation of coagulation (GO:0050820) | 3.64867431 |
| 68 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.64406292 |
| 69 | definitive hemopoiesis (GO:0060216) | 3.64368757 |
| 70 | platelet activation (GO:0030168) | 3.62006621 |
| 71 | beta-amyloid metabolic process (GO:0050435) | 3.61595153 |
| 72 | negative regulation of response to food (GO:0032096) | 3.59488531 |
| 73 | negative regulation of appetite (GO:0032099) | 3.59488531 |
| 74 | megakaryocyte development (GO:0035855) | 3.58140608 |
| 75 | polyamine biosynthetic process (GO:0006596) | 3.57262377 |
| 76 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.55296855 |
| 77 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.54269451 |
| 78 | homotypic cell-cell adhesion (GO:0034109) | 3.53742112 |
| 79 | high-density lipoprotein particle remodeling (GO:0034375) | 3.51232828 |
| 80 | iron ion import (GO:0097286) | 3.50861686 |
| 81 | regulation of appetite (GO:0032098) | 3.50733710 |
| 82 | positive regulation of protein homodimerization activity (GO:0090073) | 3.50678449 |
| 83 | positive regulation of receptor recycling (GO:0001921) | 3.50204067 |
| 84 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.47156791 |
| 85 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.44554805 |
| 86 | regulation of beta-amyloid formation (GO:1902003) | 3.44078774 |
| 87 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.41534712 |
| 88 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.39590233 |
| 89 | trabecula formation (GO:0060343) | 3.38170143 |
| 90 | regulation of lipoprotein metabolic process (GO:0050746) | 3.36627676 |
| 91 | positive regulation of focal adhesion assembly (GO:0051894) | 3.35687363 |
| 92 | positive regulation of cell junction assembly (GO:1901890) | 3.35687363 |
| 93 | auditory behavior (GO:0031223) | 3.35637701 |
| 94 | cyclic nucleotide catabolic process (GO:0009214) | 3.33609132 |
| 95 | purinergic receptor signaling pathway (GO:0035587) | 3.32675539 |
| 96 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.32236991 |
| 97 | amyloid precursor protein catabolic process (GO:0042987) | 3.31730966 |
| 98 | reverse cholesterol transport (GO:0043691) | 3.31178492 |
| 99 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.28720029 |
| 100 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.28571764 |
| 101 | establishment of protein localization to Golgi (GO:0072600) | 3.28028088 |
| 102 | polyol transport (GO:0015791) | 3.26881771 |
| 103 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.26547508 |
| 104 | negative regulation of T cell apoptotic process (GO:0070233) | 3.26405652 |
| 105 | amino acid import (GO:0043090) | 3.26011461 |
| 106 | regulation of phosphatidylinositol 3-kinase activity (GO:0043551) | 3.22847357 |
| 107 | extracellular fibril organization (GO:0043206) | 3.21110760 |
| 108 | regulation of mast cell activation (GO:0033003) | 3.20733544 |
| 109 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.20061161 |
| 110 | response to UV-C (GO:0010225) | 3.19554631 |
| 111 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.19229055 |
| 112 | leukocyte degranulation (GO:0043299) | 3.19124404 |
| 113 | negative regulation of neural precursor cell proliferation (GO:2000178) | 3.16974743 |
| 114 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 3.16771717 |
| 115 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.16667238 |
| 116 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.16634875 |
| 117 | regulation of norepinephrine secretion (GO:0014061) | 3.14183318 |
| 118 | glycerophospholipid catabolic process (GO:0046475) | 3.12827641 |
| 119 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 3.11599731 |
| 120 | membrane tubulation (GO:0097320) | 3.11356815 |
| 121 | positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068) | 3.11333209 |
| 122 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.11011030 |
| 123 | superoxide anion generation (GO:0042554) | 3.09949390 |
| 124 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.09836929 |
| 125 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 3.08595043 |
| 126 | positive regulation of interleukin-17 production (GO:0032740) | 3.08437787 |
| 127 | phospholipid homeostasis (GO:0055091) | 3.08385231 |
| 128 | regulation of lipid kinase activity (GO:0043550) | 3.06576973 |
| 129 | termination of signal transduction (GO:0023021) | 3.06485978 |
| 130 | regulation of cholesterol efflux (GO:0010874) | 3.05831389 |
| 131 | negative regulation of heart contraction (GO:0045822) | 3.05620202 |
| 132 | skeletal muscle tissue regeneration (GO:0043403) | 3.04558808 |
| 133 | mucosal immune response (GO:0002385) | 3.04048847 |
| 134 | purine ribonucleotide transport (GO:0015868) | 3.02978292 |
| 135 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.02762944 |
| 136 | positive regulation of adherens junction organization (GO:1903393) | 3.02404243 |
| 137 | regulation of memory T cell differentiation (GO:0043380) | 3.01064631 |
| 138 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.01030667 |
| 139 | establishment of epithelial cell polarity (GO:0090162) | 2.97908377 |
| 140 | regulation of vascular permeability (GO:0043114) | 2.97199172 |
| 141 | positive regulation of mast cell degranulation (GO:0043306) | 2.96903071 |
| 142 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.96903071 |
| 143 | negative regulation of neurotransmitter transport (GO:0051589) | 2.96889132 |
| 144 | mechanosensory behavior (GO:0007638) | 2.96724794 |
| 145 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.96306273 |
| 146 | mitochondrial calcium ion transport (GO:0006851) | 2.95803093 |
| 147 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.94810324 |
| 148 | regulation of blood coagulation (GO:0030193) | 2.94367088 |
| 149 | regulation of hemostasis (GO:1900046) | 2.94367088 |
| 150 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.94361131 |
| 151 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.94361131 |
| 152 | regulation of female receptivity (GO:0045924) | 2.93232884 |
| 153 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.93197815 |
| 154 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.92847760 |
| 155 | creatine metabolic process (GO:0006600) | 2.92431772 |
| 156 | regulation of mast cell degranulation (GO:0043304) | 2.92056565 |
| 157 | very long-chain fatty acid metabolic process (GO:0000038) | 2.92031086 |
| 158 | endothelial cell proliferation (GO:0001935) | 2.91541267 |
| 159 | N-terminal protein amino acid acetylation (GO:0006474) | 2.91474311 |
| 160 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.91263116 |
| 161 | peptide catabolic process (GO:0043171) | 2.90944999 |
| 162 | substantia nigra development (GO:0021762) | 2.90496433 |
| 163 | NADPH regeneration (GO:0006740) | 2.90245473 |
| 164 | protein K11-linked deubiquitination (GO:0035871) | 2.89900229 |
| 165 | S-adenosylmethionine metabolic process (GO:0046500) | 2.89733860 |
| 166 | autophagic vacuole fusion (GO:0000046) | 2.88928371 |
| 167 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.88761380 |
| 168 | adhesion of symbiont to host cell (GO:0044650) | 2.85894512 |
| 169 | virion attachment to host cell (GO:0019062) | 2.85894512 |
| 170 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.84166497 |
| 171 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.82530873 |
| 172 | organ or tissue specific immune response (GO:0002251) | 2.81846645 |
| 173 | regulation of endothelial cell differentiation (GO:0045601) | 2.80047309 |
| 174 | cAMP catabolic process (GO:0006198) | 2.79811187 |
| 175 | vesicle targeting (GO:0006903) | 2.79158648 |
| 176 | establishment of endothelial barrier (GO:0061028) | 2.76332650 |
| 177 | oligodendrocyte differentiation (GO:0048709) | 2.75972308 |
| 178 | regulation of receptor recycling (GO:0001919) | 2.75879879 |
| 179 | head development (GO:0060322) | 2.75024725 |
| 180 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.74376529 |
| 181 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.74314127 |
| 182 | negative regulation of catecholamine secretion (GO:0033604) | 2.74138440 |
| 183 | eye photoreceptor cell differentiation (GO:0001754) | 2.72259903 |
| 184 | photoreceptor cell differentiation (GO:0046530) | 2.72259903 |
| 185 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.72155116 |
| 186 | purine nucleotide transport (GO:0015865) | 2.68539000 |
| 187 | heme transport (GO:0015886) | 2.68384403 |
| 188 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.68325267 |
| 189 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.67884721 |
| 190 | myelination in peripheral nervous system (GO:0022011) | 2.67484843 |
| 191 | peripheral nervous system axon ensheathment (GO:0032292) | 2.67484843 |
| 192 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.66713509 |
| 193 | GDP-mannose metabolic process (GO:0019673) | 2.65673324 |
| 194 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 2.65074142 |
| 195 | limb bud formation (GO:0060174) | 2.64451948 |
| 196 | positive regulation of dendrite morphogenesis (GO:0050775) | 2.62607018 |
| 197 | fat-soluble vitamin biosynthetic process (GO:0042362) | 12.3067608 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 4.79478374 |
| 2 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 4.09981779 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.73705426 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.34319146 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.30055151 |
| 6 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.17971909 |
| 7 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.12442965 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.12306014 |
| 9 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.11406945 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.88808100 |
| 11 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.87292496 |
| 12 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.76720450 |
| 13 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.69778007 |
| 14 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.56229819 |
| 15 | GATA2_19941826_ChIP-Seq_K562_Human | 2.53440708 |
| 16 | SPI1_23127762_ChIP-Seq_K562_Human | 2.50726499 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.49157533 |
| 18 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.46630620 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.45769416 |
| 20 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.43325601 |
| 21 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.35625142 |
| 22 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.20184190 |
| 23 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.14711483 |
| 24 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.11693853 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.09255353 |
| 26 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.06912847 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.06101138 |
| 28 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.04241007 |
| 29 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.03337686 |
| 30 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.03216506 |
| 31 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.02849016 |
| 32 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.02798836 |
| 33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.00572522 |
| 34 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.99267669 |
| 35 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.98610323 |
| 36 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.95319395 |
| 37 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.90356282 |
| 38 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.89286647 |
| 39 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.83102992 |
| 40 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.82675518 |
| 41 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.79204555 |
| 42 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.78112470 |
| 43 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.78112470 |
| 44 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.76347032 |
| 45 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.75889784 |
| 46 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74522902 |
| 47 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.74160185 |
| 48 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73786486 |
| 49 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.72640229 |
| 50 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.72335550 |
| 51 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.70443011 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.70046629 |
| 53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.69538881 |
| 54 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.69097953 |
| 55 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65791279 |
| 56 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.65743574 |
| 57 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.62362203 |
| 58 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.59918570 |
| 59 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.58776007 |
| 60 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56755364 |
| 61 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.54507525 |
| 62 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.53798795 |
| 63 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.52812574 |
| 64 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.52468430 |
| 65 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.51165899 |
| 66 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.50222668 |
| 67 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.48333338 |
| 68 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.47590124 |
| 69 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.47524833 |
| 70 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.46415869 |
| 71 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.46200642 |
| 72 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.45695128 |
| 73 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.44482442 |
| 74 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43942466 |
| 75 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.42729744 |
| 76 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.41911872 |
| 77 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.41911872 |
| 78 | GATA1_19941826_ChIP-Seq_K562_Human | 1.41012601 |
| 79 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.40730279 |
| 80 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40357567 |
| 81 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.39371038 |
| 82 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39018971 |
| 83 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38521863 |
| 84 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.38513917 |
| 85 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.35863420 |
| 86 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.35642547 |
| 87 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.35363621 |
| 88 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.35265929 |
| 89 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.32622552 |
| 90 | EWS_26573619_Chip-Seq_HEK293_Human | 1.32363886 |
| 91 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.27328050 |
| 92 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27328050 |
| 93 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.26873061 |
| 94 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25620830 |
| 95 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.23192925 |
| 96 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21964688 |
| 97 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.21619266 |
| 98 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.20847741 |
| 99 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.20620171 |
| 100 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.19017813 |
| 101 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16386850 |
| 102 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.15888531 |
| 103 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.14262245 |
| 104 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.13842727 |
| 105 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.13793182 |
| 106 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13220132 |
| 107 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.11530801 |
| 108 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.10923012 |
| 109 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08525660 |
| 110 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.07237581 |
| 111 | CJUN_26792858_Chip-Seq_BT549_Human | 1.07231678 |
| 112 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.06807932 |
| 113 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.06524519 |
| 114 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.06324251 |
| 115 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.05086208 |
| 116 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.04991401 |
| 117 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.04865203 |
| 118 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04355389 |
| 119 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03689786 |
| 120 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02649046 |
| 121 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.02472936 |
| 122 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01985470 |
| 123 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97756369 |
| 124 | TCF4_23295773_ChIP-Seq_U87_Human | 0.97043281 |
| 125 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.96946643 |
| 126 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.96747550 |
| 127 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.96600842 |
| 128 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95997834 |
| 129 | STAT3_23295773_ChIP-Seq_U87_Human | 0.95428997 |
| 130 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.95191842 |
| 131 | P300_19829295_ChIP-Seq_ESCs_Human | 0.95081525 |
| 132 | AR_25329375_ChIP-Seq_VCAP_Human | 0.94391112 |
| 133 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.94203344 |
| 134 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.93826808 |
| 135 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 0.93364630 |
| 136 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.92523093 |
| 137 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.92221546 |
| 138 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.92174577 |
| 139 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.91565049 |
| 140 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.90744886 |
| 141 | TBL1_22424771_ChIP-Seq_293T_Human | 0.90104749 |
| 142 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.89990757 |
| 143 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.89606654 |
| 144 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89577251 |
| 145 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89264208 |
| 146 | UTX_26944678_Chip-Seq_JUKART_Human | 0.89098227 |
| 147 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.89016618 |
| 148 | JUN_21703547_ChIP-Seq_K562_Human | 0.88885385 |
| 149 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.88540846 |
| 150 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.88089658 |
| 151 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.87984273 |
| 152 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.87733682 |
| 153 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.86937476 |
| 154 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.86403945 |
| 155 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85547252 |
| 156 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.85125968 |
| 157 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.85086826 |
| 158 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.84511866 |
| 159 | KDM2B_26808549_Chip-Seq_REH_Human | 0.83490465 |
| 160 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.83321123 |
| 161 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.82467533 |
| 162 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.81642891 |
| 163 | FUS_26573619_Chip-Seq_HEK293_Human | 0.81635066 |
| 164 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81630094 |
| 165 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.81369959 |
| 166 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.81341219 |
| 167 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81305269 |
| 168 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.80840767 |
| 169 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.80431477 |
| 170 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79948549 |
| 171 | MYB_26560356_Chip-Seq_TH2_Human | 0.78473090 |
| 172 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.77860946 |
| 173 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77414761 |
| 174 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.77221906 |
| 175 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.76686791 |
| 176 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76327710 |
| 177 | TP53_16413492_ChIP-PET_HCT116_Human | 0.75855590 |
| 178 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.75599837 |
| 179 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.75554637 |
| 180 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.74655479 |
| 181 | GATA3_26560356_Chip-Seq_TH2_Human | 0.74518008 |
| 182 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73880897 |
| 183 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73806262 |
| 184 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.73751648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 9.67805802 |
| 2 | MP0000920_abnormal_myelination | 4.27127360 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 3.61460106 |
| 4 | MP0000465_gastrointestinal_hemorrhage | 3.23670467 |
| 5 | MP0005377_hearing/vestibular/ear_phenot | 3.08404983 |
| 6 | MP0003878_abnormal_ear_physiology | 3.08404983 |
| 7 | MP0003690_abnormal_glial_cell | 3.03346760 |
| 8 | MP0006138_congestive_heart_failure | 3.02547253 |
| 9 | MP0004742_abnormal_vestibular_system | 2.81038471 |
| 10 | MP0005409_darkened_coat_color | 2.77666159 |
| 11 | MP0001529_abnormal_vocalization | 2.77349677 |
| 12 | MP0005623_abnormal_meninges_morphology | 2.74890313 |
| 13 | MP0001485_abnormal_pinna_reflex | 2.73595224 |
| 14 | MP0005171_absent_coat_pigmentation | 2.58868203 |
| 15 | MP0005083_abnormal_biliary_tract | 2.57245955 |
| 16 | MP0003303_peritoneal_inflammation | 2.55551576 |
| 17 | MP0001905_abnormal_dopamine_level | 2.49423461 |
| 18 | MP0003329_amyloid_beta_deposits | 2.47466291 |
| 19 | MP0001486_abnormal_startle_reflex | 2.31292862 |
| 20 | MP0001835_abnormal_antigen_presentation | 2.27488641 |
| 21 | MP0004510_myositis | 2.26725125 |
| 22 | MP0000230_abnormal_systemic_arterial | 2.22854314 |
| 23 | MP0003183_abnormal_peptide_metabolism | 2.22479726 |
| 24 | MP0000343_altered_response_to | 2.19660936 |
| 25 | MP0005167_abnormal_blood-brain_barrier | 2.12707655 |
| 26 | MP0005410_abnormal_fertilization | 2.11614979 |
| 27 | MP0002736_abnormal_nociception_after | 2.09268029 |
| 28 | MP0001879_abnormal_lymphatic_vessel | 2.06614688 |
| 29 | MP0004134_abnormal_chest_morphology | 2.03142861 |
| 30 | MP0003566_abnormal_cell_adhesion | 2.00319650 |
| 31 | MP0002272_abnormal_nervous_system | 1.96193108 |
| 32 | MP0003880_abnormal_central_pattern | 1.95900533 |
| 33 | MP0003638_abnormal_response/metabolism_ | 1.87218143 |
| 34 | MP0005084_abnormal_gallbladder_morpholo | 1.85843560 |
| 35 | MP0003632_abnormal_nervous_system | 1.83297512 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.82554847 |
| 37 | MP0004043_abnormal_pH_regulation | 1.78837245 |
| 38 | MP0010678_abnormal_skin_adnexa | 1.76388415 |
| 39 | MP0003656_abnormal_erythrocyte_physiolo | 1.75013301 |
| 40 | MP0000579_abnormal_nail_morphology | 1.73659561 |
| 41 | MP0003634_abnormal_glial_cell | 1.73154771 |
| 42 | MP0003828_pulmonary_edema | 1.72193871 |
| 43 | MP0005671_abnormal_response_to | 1.72170747 |
| 44 | MP0002822_catalepsy | 1.66004529 |
| 45 | MP0001851_eye_inflammation | 1.65584524 |
| 46 | MP0004484_altered_response_of | 1.64843085 |
| 47 | MP0002102_abnormal_ear_morphology | 1.64816717 |
| 48 | MP0005000_abnormal_immune_tolerance | 1.64700124 |
| 49 | MP0004084_abnormal_cardiac_muscle | 1.62228601 |
| 50 | MP0004885_abnormal_endolymph | 1.61291553 |
| 51 | MP0004130_abnormal_muscle_cell | 1.60876096 |
| 52 | MP0004270_analgesia | 1.57427017 |
| 53 | MP0002108_abnormal_muscle_morphology | 1.56271062 |
| 54 | MP0008872_abnormal_physiological_respon | 1.55980152 |
| 55 | MP0002132_abnormal_respiratory_system | 1.50408998 |
| 56 | MP0000604_amyloidosis | 1.48300933 |
| 57 | MP0001663_abnormal_digestive_system | 1.47467774 |
| 58 | MP0003631_nervous_system_phenotype | 1.46996499 |
| 59 | MP0003436_decreased_susceptibility_to | 1.46978410 |
| 60 | MP0004272_abnormal_basement_membrane | 1.46407784 |
| 61 | MP0002398_abnormal_bone_marrow | 1.45618222 |
| 62 | MP0001968_abnormal_touch/_nociception | 1.43542460 |
| 63 | MP0002734_abnormal_mechanical_nocicepti | 1.39627177 |
| 64 | MP0002064_seizures | 1.36872253 |
| 65 | MP0008775_abnormal_heart_ventricle | 1.36617736 |
| 66 | MP0000249_abnormal_blood_vessel | 1.34664074 |
| 67 | MP0001533_abnormal_skeleton_physiology | 1.33301223 |
| 68 | MP0001986_abnormal_taste_sensitivity | 1.33027413 |
| 69 | MP0000778_abnormal_nervous_system | 1.32660512 |
| 70 | MP0002229_neurodegeneration | 1.31859899 |
| 71 | MP0001545_abnormal_hematopoietic_system | 1.31164234 |
| 72 | MP0005397_hematopoietic_system_phenotyp | 1.31164234 |
| 73 | MP0004947_skin_inflammation | 1.31079888 |
| 74 | MP0002723_abnormal_immune_serum | 1.29229209 |
| 75 | MP0008004_abnormal_stomach_pH | 1.28071520 |
| 76 | MP0004019_abnormal_vitamin_homeostasis | 1.27563288 |
| 77 | MP0005165_increased_susceptibility_to | 1.26833250 |
| 78 | MP0001800_abnormal_humoral_immune | 1.25104088 |
| 79 | MP0002452_abnormal_antigen_presenting | 1.23769364 |
| 80 | MP0003950_abnormal_plasma_membrane | 1.23298948 |
| 81 | MP0004036_abnormal_muscle_relaxation | 1.21276965 |
| 82 | MP0000462_abnormal_digestive_system | 1.20091967 |
| 83 | MP0003633_abnormal_nervous_system | 1.19717303 |
| 84 | MP0001177_atelectasis | 1.19639889 |
| 85 | MP0001440_abnormal_grooming_behavior | 1.19333412 |
| 86 | MP0000383_abnormal_hair_follicle | 1.19294778 |
| 87 | MP0010329_abnormal_lipoprotein_level | 1.18904796 |
| 88 | MP0002419_abnormal_innate_immunity | 1.16534087 |
| 89 | MP0001346_abnormal_lacrimal_gland | 1.16466964 |
| 90 | MP0001970_abnormal_pain_threshold | 1.16426415 |
| 91 | MP0003453_abnormal_keratinocyte_physiol | 1.16009071 |
| 92 | MP0009763_increased_sensitivity_to | 1.15478267 |
| 93 | MP0000566_synostosis | 1.15031780 |
| 94 | MP0009764_decreased_sensitivity_to | 1.14753347 |
| 95 | MP0003879_abnormal_hair_cell | 1.14396998 |
| 96 | MP0005646_abnormal_pituitary_gland | 1.14366630 |
| 97 | MP0008874_decreased_physiological_sensi | 1.14043828 |
| 98 | MP0003866_abnormal_defecation | 1.13920252 |
| 99 | MP0000685_abnormal_immune_system | 1.13811123 |
| 100 | MP0010234_abnormal_vibrissa_follicle | 1.11508283 |
| 101 | MP0002420_abnormal_adaptive_immunity | 1.10502952 |
| 102 | MP0005310_abnormal_salivary_gland | 1.10205768 |
| 103 | MP0001819_abnormal_immune_cell | 1.09178614 |
| 104 | MP0002429_abnormal_blood_cell | 1.08762344 |
| 105 | MP0002098_abnormal_vibrissa_morphology | 1.08550521 |
| 106 | MP0005025_abnormal_response_to | 1.08242044 |
| 107 | MP0004859_abnormal_synaptic_plasticity | 1.07810595 |
| 108 | MP0004142_abnormal_muscle_tone | 1.07199589 |
| 109 | MP0005386_behavior/neurological_phenoty | 1.06810806 |
| 110 | MP0004924_abnormal_behavior | 1.06810806 |
| 111 | MP0006276_abnormal_autonomic_nervous | 1.06000571 |
| 112 | MP0002572_abnormal_emotion/affect_behav | 1.05925719 |
| 113 | MP0001845_abnormal_inflammatory_respons | 1.04874063 |
| 114 | MP0001873_stomach_inflammation | 1.04434092 |
| 115 | MP0002653_abnormal_ependyma_morphology | 1.04407045 |
| 116 | MP0001963_abnormal_hearing_physiology | 1.02138017 |
| 117 | MP0000689_abnormal_spleen_morphology | 1.02015663 |
| 118 | MP0006082_CNS_inflammation | 1.01948565 |
| 119 | MP0002557_abnormal_social/conspecific_i | 1.01161008 |
| 120 | MP0009642_abnormal_blood_homeostasis | 1.00191641 |
| 121 | MP0001790_abnormal_immune_system | 0.98872914 |
| 122 | MP0005387_immune_system_phenotype | 0.98872914 |
| 123 | MP0000858_altered_metastatic_potential | 0.97637644 |
| 124 | MP0002722_abnormal_immune_system | 0.96150684 |
| 125 | MP0002295_abnormal_pulmonary_circulatio | 0.95632891 |
| 126 | MP0000716_abnormal_immune_system | 0.95083392 |
| 127 | MP0004381_abnormal_hair_follicle | 0.92903578 |
| 128 | MP0002063_abnormal_learning/memory/cond | 0.91445490 |
| 129 | MP0003724_increased_susceptibility_to | 0.91140604 |
| 130 | MP0005381_digestive/alimentary_phenotyp | 0.90930407 |
| 131 | MP0002733_abnormal_thermal_nociception | 0.90862794 |
| 132 | MP0009697_abnormal_copulation | 0.90123724 |
| 133 | MP0000613_abnormal_salivary_gland | 0.89593414 |
| 134 | MP0004215_abnormal_myocardial_fiber | 0.89118906 |
| 135 | MP0005058_abnormal_lysosome_morphology | 0.89100470 |
| 136 | MP0002882_abnormal_neuron_morphology | 0.88267548 |
| 137 | MP0002066_abnormal_motor_capabilities/c | 0.86861128 |
| 138 | MP0000955_abnormal_spinal_cord | 0.86243787 |
| 139 | MP0005388_respiratory_system_phenotype | 0.85984839 |
| 140 | MP0002133_abnormal_respiratory_system | 0.85984839 |
| 141 | MP0003635_abnormal_synaptic_transmissio | 0.85588096 |
| 142 | MP0005670_abnormal_white_adipose | 0.85059757 |
| 143 | MP0005551_abnormal_eye_electrophysiolog | 0.84868221 |
| 144 | MP0009046_muscle_twitch | 0.84768334 |
| 145 | MP0005647_abnormal_sex_gland | 0.84393096 |
| 146 | MP0000015_abnormal_ear_pigmentation | 0.83948263 |
| 147 | MP0009333_abnormal_splenocyte_physiolog | 0.83647820 |
| 148 | MP0000647_abnormal_sebaceous_gland | 0.82798011 |
| 149 | MP0006054_spinal_hemorrhage | 0.79469792 |
| 150 | MP0002148_abnormal_hypersensitivity_rea | 0.78958289 |
| 151 | MP0009745_abnormal_behavioral_response | 0.78606239 |
| 152 | MP0000747_muscle_weakness | 0.77793231 |
| 153 | MP0003300_gastrointestinal_ulcer | 0.76859794 |
| 154 | MP0000733_abnormal_muscle_development | 0.76471584 |
| 155 | MP0001664_abnormal_digestion | 0.75915180 |
| 156 | MP0009765_abnormal_xenobiotic_induced | 0.75551315 |
| 157 | MP0002067_abnormal_sensory_capabilities | 0.75468483 |
| 158 | MP0003195_calcinosis | 0.75054228 |
| 159 | MP0009840_abnormal_foam_cell | 0.74389103 |
| 160 | MP0005408_hypopigmentation | 0.73695196 |
| 161 | MP0002998_abnormal_bone_remodeling | 0.73521714 |
| 162 | MP0002752_abnormal_somatic_nervous | 0.73159919 |
| 163 | MP0002735_abnormal_chemical_nociception | 0.72555521 |
| 164 | MP0002796_impaired_skin_barrier | 0.72406132 |
| 165 | MP0005666_abnormal_adipose_tissue | 0.71586086 |
| 166 | MP0001765_abnormal_ion_homeostasis | 0.70403262 |
| 167 | MP0003075_altered_response_to | 0.70379781 |
| 168 | MP0003136_yellow_coat_color | 0.69986170 |
| 169 | MP0002118_abnormal_lipid_homeostasis | 0.69542649 |
| 170 | MP0009278_abnormal_bone_marrow | 0.68737552 |
| 171 | MP0002972_abnormal_cardiac_muscle | 0.67472432 |
| 172 | MP0000467_abnormal_esophagus_morphology | 0.67294500 |
| 173 | MP0001544_abnormal_cardiovascular_syste | 0.65831358 |
| 174 | MP0005385_cardiovascular_system_phenoty | 0.65831358 |
| 175 | MP0000762_abnormal_tongue_morphology | 0.65060066 |
| 176 | MP0000490_abnormal_crypts_of | 0.64149383 |
| 177 | MP0005187_abnormal_penis_morphology | 0.63506361 |
| 178 | MP0005174_abnormal_tail_pigmentation | 0.63410877 |
| 179 | MP0006036_abnormal_mitochondrial_physio | 0.63320009 |
| 180 | MP0009785_altered_susceptibility_to | 0.62177441 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal platelet volume (HP:0011876) | 9.75311300 |
| 2 | Epistaxis (HP:0000421) | 7.65095793 |
| 3 | Hyperlipoproteinemia (HP:0010980) | 6.35368913 |
| 4 | Gingival bleeding (HP:0000225) | 6.30516423 |
| 5 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.85981258 |
| 6 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.85981258 |
| 7 | Abnormal platelet function (HP:0011869) | 5.34563349 |
| 8 | Impaired platelet aggregation (HP:0003540) | 5.34563349 |
| 9 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 4.69139275 |
| 10 | Abnormality of the corticospinal tract (HP:0002492) | 4.53924503 |
| 11 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 4.22774838 |
| 12 | Poikilocytosis (HP:0004447) | 4.12313263 |
| 13 | Neurofibrillary tangles (HP:0002185) | 4.08857181 |
| 14 | Spontaneous hematomas (HP:0007420) | 4.06845865 |
| 15 | Acanthocytosis (HP:0001927) | 3.86772589 |
| 16 | Absent hand (HP:0004050) | 3.84863417 |
| 17 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.82474713 |
| 18 | Petechiae (HP:0000967) | 3.77567092 |
| 19 | Increased circulating renin level (HP:0000848) | 3.75162575 |
| 20 | Dyschromatopsia (HP:0007641) | 3.69186215 |
| 21 | Metabolic alkalosis (HP:0200114) | 3.59470881 |
| 22 | Parakeratosis (HP:0001036) | 3.52003517 |
| 23 | Hypoplasia of the uterus (HP:0000013) | 3.48616794 |
| 24 | Conjunctival telangiectasia (HP:0000524) | 3.44600187 |
| 25 | Hypomagnesemia (HP:0002917) | 3.40072770 |
| 26 | Bruising susceptibility (HP:0000978) | 3.39423035 |
| 27 | Annular pancreas (HP:0001734) | 3.37096267 |
| 28 | Breast hypoplasia (HP:0003187) | 3.36910486 |
| 29 | Abnormal pupillary function (HP:0007686) | 3.31022308 |
| 30 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.29646163 |
| 31 | Abnormality of the common coagulation pathway (HP:0010990) | 3.27187223 |
| 32 | Esophageal atresia (HP:0002032) | 3.19774483 |
| 33 | Progressive external ophthalmoplegia (HP:0000590) | 3.18750096 |
| 34 | Cerebral hypomyelination (HP:0006808) | 3.17535224 |
| 35 | Abnormality of lateral ventricle (HP:0030047) | 3.09595558 |
| 36 | Tetany (HP:0001281) | 3.09160687 |
| 37 | Increased IgM level (HP:0003496) | 3.07985308 |
| 38 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.04717583 |
| 39 | Thick nail (HP:0001805) | 3.03146838 |
| 40 | Stomatitis (HP:0010280) | 3.03117426 |
| 41 | Conical tooth (HP:0000698) | 3.01513939 |
| 42 | Hypokalemic alkalosis (HP:0001949) | 2.99823772 |
| 43 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.98019960 |
| 44 | Hemorrhage of the eye (HP:0011885) | 2.89915779 |
| 45 | Abnormality of incisor morphology (HP:0011063) | 2.88495161 |
| 46 | Onion bulb formation (HP:0003383) | 2.86850061 |
| 47 | Tinnitus (HP:0000360) | 2.82773232 |
| 48 | Increased density of long bones (HP:0006392) | 2.82693252 |
| 49 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.79618729 |
| 50 | Cerebral inclusion bodies (HP:0100314) | 2.78470582 |
| 51 | Peripheral hypomyelination (HP:0007182) | 2.76359918 |
| 52 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.71928962 |
| 53 | Asplenia (HP:0001746) | 2.70103400 |
| 54 | Abnormality of macrophages (HP:0004311) | 2.70001964 |
| 55 | 3-Methylglutaconic aciduria (HP:0003535) | 2.69260768 |
| 56 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.67088836 |
| 57 | Leukodystrophy (HP:0002415) | 2.61143100 |
| 58 | Supranuclear gaze palsy (HP:0000605) | 2.60569495 |
| 59 | Hypoplastic nipples (HP:0002557) | 2.57965799 |
| 60 | Abnormality of magnesium homeostasis (HP:0004921) | 2.56206532 |
| 61 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.53678371 |
| 62 | Encephalitis (HP:0002383) | 2.51509336 |
| 63 | Abnormality of the 2nd finger (HP:0004100) | 2.48313305 |
| 64 | Alacrima (HP:0000522) | 2.46074309 |
| 65 | Joint swelling (HP:0001386) | 2.45624498 |
| 66 | Axonal loss (HP:0003447) | 2.41974981 |
| 67 | Ridged nail (HP:0001807) | 2.41319831 |
| 68 | Dysmetria (HP:0001310) | 2.41057018 |
| 69 | Ventricular fibrillation (HP:0001663) | 2.40958856 |
| 70 | Abnormal auditory evoked potentials (HP:0006958) | 2.40908341 |
| 71 | Decreased central vision (HP:0007663) | 2.37189899 |
| 72 | Sensory axonal neuropathy (HP:0003390) | 2.31771735 |
| 73 | Arterial thrombosis (HP:0004420) | 2.31641379 |
| 74 | Joint hemorrhage (HP:0005261) | 2.30533341 |
| 75 | Hyperactive renin-angiotensin system (HP:0000841) | 2.26504856 |
| 76 | Blue irides (HP:0000635) | 2.25531507 |
| 77 | Retinal dysplasia (HP:0007973) | 2.25126110 |
| 78 | Spastic gait (HP:0002064) | 2.24819944 |
| 79 | Increased CSF protein (HP:0002922) | 2.23279601 |
| 80 | Premature skin wrinkling (HP:0100678) | 2.21849158 |
| 81 | Glucose intolerance (HP:0000833) | 2.21632485 |
| 82 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.21557443 |
| 83 | Ankle clonus (HP:0011448) | 2.20626131 |
| 84 | Delayed epiphyseal ossification (HP:0002663) | 2.19414625 |
| 85 | Abnormality of iron homeostasis (HP:0011031) | 2.18975410 |
| 86 | Congenital sensorineural hearing impairment (HP:0008527) | 2.18759269 |
| 87 | Episodic fever (HP:0001954) | 2.18126192 |
| 88 | Generalized aminoaciduria (HP:0002909) | 2.18021730 |
| 89 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.17744766 |
| 90 | Morphological abnormality of the inner ear (HP:0011390) | 2.17355475 |
| 91 | Intention tremor (HP:0002080) | 2.15972521 |
| 92 | Dysautonomia (HP:0002459) | 2.15309555 |
| 93 | Vertigo (HP:0002321) | 2.10360873 |
| 94 | Insidious onset (HP:0003587) | 2.09312968 |
| 95 | Termporal pattern (HP:0011008) | 2.09312968 |
| 96 | Upper limb muscle weakness (HP:0003484) | 2.08310451 |
| 97 | Abnormal ciliary motility (HP:0012262) | 2.06750021 |
| 98 | Abnormal pancreas size (HP:0012094) | 2.05531577 |
| 99 | Basal ganglia calcification (HP:0002135) | 2.05344673 |
| 100 | Male infertility (HP:0003251) | 2.04983107 |
| 101 | Chronic obstructive pulmonary disease (HP:0006510) | 2.04088974 |
| 102 | Obstructive lung disease (HP:0006536) | 2.04088974 |
| 103 | Purpura (HP:0000979) | 2.04075407 |
| 104 | Ectopic kidney (HP:0000086) | 2.02686641 |
| 105 | Hyperaldosteronism (HP:0000859) | 2.00657078 |
| 106 | Symptomatic seizures (HP:0011145) | 2.00647013 |
| 107 | Duplicated collecting system (HP:0000081) | 2.00517769 |
| 108 | Prolonged bleeding time (HP:0003010) | 11.7981094 |
| 109 | Menorrhagia (HP:0000132) | 10.5659672 |
| 110 | Increased mean platelet volume (HP:0011877) | 10.2701036 |
| 111 | Decreased lacrimation (HP:0000633) | 1.99265127 |
| 112 | Nausea (HP:0002018) | 1.98475185 |
| 113 | Humeroradial synostosis (HP:0003041) | 1.97434159 |
| 114 | Synostosis involving the elbow (HP:0003938) | 1.97434159 |
| 115 | Eczematoid dermatitis (HP:0000976) | 1.96874406 |
| 116 | Peripheral demyelination (HP:0011096) | 1.96060598 |
| 117 | Polydipsia (HP:0001959) | 1.94265118 |
| 118 | Abnormal drinking behavior (HP:0030082) | 1.94265118 |
| 119 | Absent/shortened dynein arms (HP:0200106) | 1.94188315 |
| 120 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.94188315 |
| 121 | Coronal craniosynostosis (HP:0004440) | 1.93587843 |
| 122 | Truncus arteriosus (HP:0001660) | 1.91911936 |
| 123 | Action tremor (HP:0002345) | 1.90114069 |
| 124 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89499355 |
| 125 | Retrobulbar optic neuritis (HP:0100654) | 1.89124493 |
| 126 | Optic neuritis (HP:0100653) | 1.89124493 |
| 127 | Absent septum pellucidum (HP:0001331) | 1.88835361 |
| 128 | Anteriorly placed anus (HP:0001545) | 1.87901485 |
| 129 | Polycythemia (HP:0001901) | 1.84689093 |
| 130 | Increased serum ferritin (HP:0003281) | 1.84520368 |
| 131 | Slow saccadic eye movements (HP:0000514) | 1.84302054 |
| 132 | Papillary thyroid carcinoma (HP:0002895) | 1.81841472 |
| 133 | Bilateral microphthalmos (HP:0007633) | 1.81382097 |
| 134 | Thyroid-stimulating hormone excess (HP:0002925) | 1.81277316 |
| 135 | Scapular winging (HP:0003691) | 1.80409716 |
| 136 | Arthropathy (HP:0003040) | 1.80250043 |
| 137 | Cone-rod dystrophy (HP:0000548) | 1.80196650 |
| 138 | Spontaneous abortion (HP:0005268) | 1.79094599 |
| 139 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.77922844 |
| 140 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.77922844 |
| 141 | Supernumerary ribs (HP:0005815) | 1.77748581 |
| 142 | Increased IgE level (HP:0003212) | 1.77603401 |
| 143 | Tongue fasciculations (HP:0001308) | 1.77027293 |
| 144 | Muscle fibrillation (HP:0010546) | 1.77014892 |
| 145 | Hypoplastic pelvis (HP:0008839) | 1.76615214 |
| 146 | Microretrognathia (HP:0000308) | 1.76217896 |
| 147 | Keratoconjunctivitis (HP:0001096) | 1.75229720 |
| 148 | Clumsiness (HP:0002312) | 1.74922957 |
| 149 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.74906943 |
| 150 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.73951763 |
| 151 | Biliary tract neoplasm (HP:0100574) | 1.73103468 |
| 152 | Spastic paraparesis (HP:0002313) | 1.72646551 |
| 153 | Abnormality of the renal collecting system (HP:0004742) | 1.72014359 |
| 154 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.71257301 |
| 155 | Xanthomatosis (HP:0000991) | 1.70161377 |
| 156 | Paralysis (HP:0003470) | 1.69371389 |
| 157 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.68536678 |
| 158 | Aplasia of the phalanges of the hand (HP:0009802) | 1.68536678 |
| 159 | Aplasia involving bones of the extremities (HP:0009825) | 1.68536678 |
| 160 | Abnormal glucose tolerance (HP:0001952) | 1.68222337 |
| 161 | Hepatosplenomegaly (HP:0001433) | 1.67909279 |
| 162 | Renal salt wasting (HP:0000127) | 1.67824601 |
| 163 | Dysostosis multiplex (HP:0000943) | 1.65125977 |
| 164 | Myocardial infarction (HP:0001658) | 1.64248772 |
| 165 | Abnormality of the prostate (HP:0008775) | 1.64058546 |
| 166 | Orchitis (HP:0100796) | 1.64032412 |
| 167 | Keratoconjunctivitis sicca (HP:0001097) | 1.63552149 |
| 168 | Infertility (HP:0000789) | 1.62260921 |
| 169 | Hypophosphatemic rickets (HP:0004912) | 1.61355327 |
| 170 | Ileus (HP:0002595) | 1.61119782 |
| 171 | Hyperthyroidism (HP:0000836) | 1.59538578 |
| 172 | Testicular neoplasm (HP:0010788) | 1.59069656 |
| 173 | Chest pain (HP:0100749) | 1.57790921 |
| 174 | Distal lower limb amyotrophy (HP:0008944) | 1.57316020 |
| 175 | Thrombophlebitis (HP:0004418) | 1.56595497 |
| 176 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.55106072 |
| 177 | Myositis (HP:0100614) | 1.53447462 |
| 178 | Pulmonary embolism (HP:0002204) | 1.50306391 |
| 179 | Recurrent abscess formation (HP:0002722) | 1.48335979 |
| 180 | Autoimmune hemolytic anemia (HP:0001890) | 1.46554394 |
| 181 | Cerebral ischemia (HP:0002637) | 1.46212854 |
| 182 | Abolished electroretinogram (ERG) (HP:0000550) | 1.45729783 |
| 183 | Abnormality of binocular vision (HP:0011514) | 1.44582214 |
| 184 | Diplopia (HP:0000651) | 1.44582214 |
| 185 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.41847934 |
| 186 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.39957336 |
| 187 | Abnormality of alanine metabolism (HP:0010916) | 1.39957336 |
| 188 | Hyperalaninemia (HP:0003348) | 1.39957336 |
| 189 | Recurrent bacterial skin infections (HP:0005406) | 1.39071352 |
| 190 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.38303052 |
| 191 | Polyphagia (HP:0002591) | 1.37416587 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.13912258 |
| 2 | MYLK | 3.60419023 |
| 3 | BTK | 3.08221430 |
| 4 | BMX | 3.02342517 |
| 5 | GRK1 | 2.91330894 |
| 6 | PTK2B | 2.69018612 |
| 7 | EIF2AK1 | 2.67205363 |
| 8 | STK39 | 2.54973148 |
| 9 | TAOK3 | 2.47746989 |
| 10 | BLK | 2.40438757 |
| 11 | CAMK1D | 2.39051723 |
| 12 | TEC | 2.37067971 |
| 13 | SYK | 2.25664196 |
| 14 | CSF1R | 2.24497813 |
| 15 | MAPKAPK5 | 2.17014046 |
| 16 | GRK5 | 2.15639852 |
| 17 | ZAP70 | 2.14330127 |
| 18 | GRK6 | 2.09408473 |
| 19 | MAPKAPK3 | 2.02416213 |
| 20 | TIE1 | 13.1409311 |
| 21 | ILK | 1.95836568 |
| 22 | TNIK | 1.93081624 |
| 23 | CAMK1G | 1.91512446 |
| 24 | TXK | 1.90016800 |
| 25 | PIK3CG | 1.79636359 |
| 26 | PBK | 1.72260105 |
| 27 | FRK | 1.62961302 |
| 28 | OXSR1 | 1.48443443 |
| 29 | HCK | 1.46706412 |
| 30 | TNK2 | 1.34258764 |
| 31 | EPHB1 | 1.32328288 |
| 32 | STK3 | 1.31230269 |
| 33 | BCR | 1.30573686 |
| 34 | LYN | 1.29310519 |
| 35 | ICK | 1.25232105 |
| 36 | TSSK6 | 1.24507446 |
| 37 | PKN1 | 1.24436034 |
| 38 | PLK2 | 1.21940777 |
| 39 | UHMK1 | 1.21134020 |
| 40 | MAP2K3 | 1.19167895 |
| 41 | IRAK1 | 1.15739815 |
| 42 | PAK1 | 1.15476407 |
| 43 | TRPM7 | 1.14867133 |
| 44 | SGK223 | 1.13298562 |
| 45 | SGK494 | 1.13298562 |
| 46 | DAPK3 | 1.07933013 |
| 47 | LMTK2 | 1.07591334 |
| 48 | FER | 1.03269234 |
| 49 | MET | 1.01476005 |
| 50 | NEK6 | 1.00590517 |
| 51 | STK24 | 1.00217476 |
| 52 | ACVR1B | 0.97653975 |
| 53 | MATK | 0.96800331 |
| 54 | DAPK2 | 0.90511671 |
| 55 | ITK | 0.90074409 |
| 56 | SIK3 | 0.89258873 |
| 57 | EPHA3 | 0.88680520 |
| 58 | FGFR2 | 0.88556519 |
| 59 | ADRBK1 | 0.87647415 |
| 60 | MARK3 | 0.84580819 |
| 61 | WNK4 | 0.84223653 |
| 62 | TLK1 | 0.83120771 |
| 63 | MAPK13 | 0.82153472 |
| 64 | ERBB2 | 0.79567652 |
| 65 | PIM2 | 0.79555326 |
| 66 | PRKCE | 0.79147335 |
| 67 | PRKCG | 0.78809013 |
| 68 | YES1 | 0.78783290 |
| 69 | TAOK2 | 0.78565480 |
| 70 | MST4 | 0.76837935 |
| 71 | WNK3 | 0.75955919 |
| 72 | CSNK1A1L | 0.74563195 |
| 73 | GRK7 | 0.74209390 |
| 74 | MAP2K2 | 0.74083850 |
| 75 | CSNK1G3 | 0.73208938 |
| 76 | MKNK1 | 0.73196273 |
| 77 | PINK1 | 0.72521464 |
| 78 | RET | 0.71427128 |
| 79 | MAP3K5 | 0.71212239 |
| 80 | CAMK2B | 0.70470571 |
| 81 | CLK1 | 0.70307714 |
| 82 | NTRK1 | 0.69456180 |
| 83 | PRPF4B | 0.67995113 |
| 84 | PDK1 | 0.66240025 |
| 85 | TAOK1 | 0.65008739 |
| 86 | TESK2 | 0.64193996 |
| 87 | ROCK2 | 0.61777588 |
| 88 | KDR | 0.60967945 |
| 89 | MAP4K1 | 0.60252670 |
| 90 | MAP3K3 | 0.57682991 |
| 91 | BMPR1B | 0.57105149 |
| 92 | IKBKB | 0.56904953 |
| 93 | EPHB2 | 0.56275359 |
| 94 | DAPK1 | 0.55476710 |
| 95 | IRAK2 | 0.54906586 |
| 96 | TYRO3 | 0.54704481 |
| 97 | ADRBK2 | 0.54636681 |
| 98 | EPHA4 | 0.54402400 |
| 99 | LCK | 0.54354612 |
| 100 | CSNK1G2 | 0.54099288 |
| 101 | ZAK | 0.54050349 |
| 102 | CSNK1G1 | 0.53241577 |
| 103 | PDPK1 | 0.52580129 |
| 104 | TRIM28 | 0.52124140 |
| 105 | PIK3CA | 0.51123147 |
| 106 | PAK3 | 0.50797947 |
| 107 | PRKACG | 0.49474294 |
| 108 | NUAK1 | 0.47746402 |
| 109 | FES | 0.46617602 |
| 110 | DYRK2 | 0.45886438 |
| 111 | INSRR | 0.43979540 |
| 112 | CAMK2D | 0.43975104 |
| 113 | PDGFRB | 0.43361917 |
| 114 | PAK6 | 0.43206170 |
| 115 | JAK2 | 0.42461616 |
| 116 | BMPR2 | 0.41262277 |
| 117 | JAK1 | 0.40039130 |
| 118 | PRKCQ | 0.39658107 |
| 119 | KSR2 | 0.38321900 |
| 120 | LIMK1 | 0.38301877 |
| 121 | CDK19 | 0.35896832 |
| 122 | CAMK2A | 0.35443029 |
| 123 | IRAK4 | 0.33297761 |
| 124 | SGK2 | 0.33021775 |
| 125 | WNK1 | 0.32926737 |
| 126 | MINK1 | 0.32387953 |
| 127 | IGF1R | 0.31953667 |
| 128 | CSNK1D | 0.31896602 |
| 129 | INSR | 0.31781056 |
| 130 | MAP3K11 | 0.31141534 |
| 131 | JAK3 | 0.31058983 |
| 132 | IRAK3 | 0.30888246 |
| 133 | MARK1 | 0.30709155 |
| 134 | PRKD1 | 0.29580468 |
| 135 | CAMKK2 | 0.28735460 |
| 136 | STK4 | 0.26984888 |
| 137 | SGK3 | 0.26533813 |
| 138 | MAP4K2 | 0.25780119 |
| 139 | GSK3A | 0.25455638 |
| 140 | PRKCD | 0.25064788 |
| 141 | CAMK1 | 0.24338473 |
| 142 | ROCK1 | 0.23741962 |
| 143 | SRC | 0.23638153 |
| 144 | EGFR | 0.23115600 |
| 145 | PRKAA2 | 0.22787430 |
| 146 | ARAF | 0.22705931 |
| 147 | PIM1 | 0.21755501 |
| 148 | PRKCI | 0.21619723 |
| 149 | BUB1 | 0.21554687 |
| 150 | FYN | 0.21422615 |
| 151 | MAPK4 | 0.20963335 |
| 152 | MAPK12 | 0.20845705 |
| 153 | CAMK4 | 0.20598738 |
| 154 | PRKCA | 0.20191811 |
| 155 | FGR | 0.18895667 |
| 156 | CAMK2G | 0.18460121 |
| 157 | MARK2 | 0.17157603 |
| 158 | MAP2K1 | 0.16715079 |
| 159 | CDK5 | 0.16510508 |
| 160 | PRKCB | 0.16308452 |
| 161 | PRKACA | 0.14866894 |
| 162 | PRKCZ | 0.14783343 |
| 163 | PNCK | 0.14426153 |
| 164 | EIF2AK2 | 0.14154411 |
| 165 | CSNK1A1 | 0.14051700 |
| 166 | CDK14 | 0.13617067 |
| 167 | SGK1 | 0.13549311 |
| 168 | PRKG1 | 0.13118472 |
| 169 | PRKCH | 0.12460622 |
| 170 | CSK | 0.12263711 |
| 171 | MAP3K2 | 0.12254329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.58749100 |
| 2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.53919701 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.44432650 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.41781539 |
| 5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.65963726 |
| 6 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.53042323 |
| 7 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.50051483 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.48456537 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.43593173 |
| 10 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.36886617 |
| 11 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 2.21509744 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.94714627 |
| 13 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.84330115 |
| 14 | Bile secretion_Homo sapiens_hsa04976 | 1.71166438 |
| 15 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.68214476 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.56268952 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.48493281 |
| 18 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.47583703 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.47289786 |
| 20 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.40275784 |
| 21 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.40017472 |
| 22 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.37686734 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.36919725 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.36684053 |
| 25 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.36560775 |
| 26 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.36083089 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.35353314 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.31797099 |
| 29 | Morphine addiction_Homo sapiens_hsa05032 | 1.26853220 |
| 30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.23870848 |
| 31 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.23054375 |
| 32 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.22243751 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.21757321 |
| 34 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.20351007 |
| 35 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.19922123 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.19625545 |
| 37 | Alcoholism_Homo sapiens_hsa05034 | 1.18956366 |
| 38 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.17908775 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.17353791 |
| 40 | Axon guidance_Homo sapiens_hsa04360 | 1.15192652 |
| 41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14963248 |
| 42 | Olfactory transduction_Homo sapiens_hsa04740 | 1.14263375 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 1.13872792 |
| 44 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.13568878 |
| 45 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.10651268 |
| 46 | Taste transduction_Homo sapiens_hsa04742 | 1.09755424 |
| 47 | Long-term depression_Homo sapiens_hsa04730 | 1.06934537 |
| 48 | Ras signaling pathway_Homo sapiens_hsa04014 | 1.06380405 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.02378199 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01590051 |
| 51 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.01110108 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.01097205 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.01080915 |
| 54 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.00773396 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 0.98447631 |
| 56 | Mineral absorption_Homo sapiens_hsa04978 | 0.97408851 |
| 57 | GABAergic synapse_Homo sapiens_hsa04727 | 0.96370096 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.96031930 |
| 59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.95721503 |
| 60 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.94210535 |
| 61 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.94023976 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.90576936 |
| 63 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.89990992 |
| 64 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.89085066 |
| 65 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.87329719 |
| 66 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.86666759 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86529018 |
| 68 | Alzheimers disease_Homo sapiens_hsa05010 | 0.86421288 |
| 69 | Gap junction_Homo sapiens_hsa04540 | 0.80462863 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 0.79072085 |
| 71 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.78925458 |
| 72 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.76066618 |
| 73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76024216 |
| 74 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75497497 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.74887419 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.74091743 |
| 77 | Melanogenesis_Homo sapiens_hsa04916 | 0.72738509 |
| 78 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71741217 |
| 79 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.70132641 |
| 80 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.69220588 |
| 81 | Protein export_Homo sapiens_hsa03060 | 0.69141151 |
| 82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.69123994 |
| 83 | Peroxisome_Homo sapiens_hsa04146 | 0.66542536 |
| 84 | Parkinsons disease_Homo sapiens_hsa05012 | 0.66500991 |
| 85 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66278415 |
| 86 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.65759961 |
| 87 | Circadian entrainment_Homo sapiens_hsa04713 | 0.64379538 |
| 88 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.64275587 |
| 89 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64051611 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.64051546 |
| 91 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.63463320 |
| 92 | Tight junction_Homo sapiens_hsa04530 | 0.62197072 |
| 93 | Phototransduction_Homo sapiens_hsa04744 | 0.61435739 |
| 94 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61211419 |
| 95 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60721359 |
| 96 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.59763678 |
| 97 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.59347134 |
| 98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58531517 |
| 99 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.57827988 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57691835 |
| 101 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.56234506 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.55485161 |
| 103 | Allograft rejection_Homo sapiens_hsa05330 | 0.54693634 |
| 104 | Prostate cancer_Homo sapiens_hsa05215 | 0.54002478 |
| 105 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53946287 |
| 106 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53925108 |
| 107 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52861163 |
| 108 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.50121791 |
| 109 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.49631912 |
| 110 | Asthma_Homo sapiens_hsa05310 | 0.49341025 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48682741 |
| 112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48639322 |
| 113 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.48292723 |
| 114 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47714494 |
| 115 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.47406040 |
| 116 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46432544 |
| 117 | Mismatch repair_Homo sapiens_hsa03430 | 0.46177792 |
| 118 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.45837212 |
| 119 | Leishmaniasis_Homo sapiens_hsa05140 | 0.44446250 |
| 120 | Apoptosis_Homo sapiens_hsa04210 | 0.44197831 |
| 121 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.43350606 |
| 122 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.43215724 |
| 123 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43157891 |
| 124 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.42095016 |
| 125 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42059829 |
| 126 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.41680656 |
| 127 | Platelet activation_Homo sapiens_hsa04611 | 0.41201464 |
| 128 | Legionellosis_Homo sapiens_hsa05134 | 0.40656933 |
| 129 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40213370 |
| 130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39372225 |
| 131 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.39265309 |
| 132 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.38475561 |
| 133 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.38203832 |
| 134 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.37836724 |
| 135 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.37521038 |
| 136 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37467730 |
| 137 | Salmonella infection_Homo sapiens_hsa05132 | 0.37090141 |
| 138 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36612597 |
| 139 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.36084977 |
| 140 | Amoebiasis_Homo sapiens_hsa05146 | 0.35994738 |
| 141 | Prion diseases_Homo sapiens_hsa05020 | 0.35800749 |
| 142 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34510558 |
| 143 | Hepatitis C_Homo sapiens_hsa05160 | 0.33079429 |
| 144 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.32260151 |
| 145 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.31583494 |
| 146 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.29780078 |
| 147 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.28513338 |
| 148 | Insulin secretion_Homo sapiens_hsa04911 | 0.26785067 |
| 149 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26508587 |
| 150 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.26375366 |
| 151 | Malaria_Homo sapiens_hsa05144 | 0.26158478 |
| 152 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.22526927 |
| 153 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.21652333 |
| 154 | Phagosome_Homo sapiens_hsa04145 | 0.21647678 |

